Amass, Leslie
Li, Huihua
Gundapaneni, Balarama K.
Schwartz, Jeffrey H.
Keohane, Denis J.
Funding for this research was provided by:
Pfizer
Article History
Received: 6 December 2017
Accepted: 30 October 2018
First Online: 17 December 2018
Ethics approval and consent to participate
: All studies that contributed data to the present analysis were conducted with the approval of local institutional review boards or independent ethics committees (Additional file InternalRef removed: Table S1). The studies complied with the Declaration of Helsinki, the International Conference on Harmonisation Guideline for Good Clinical Practice, and local regulatory requirements. All patients provided written informed consent.
: Not applicable.
: L Amass, H Li, J Schwartz, and D Keohane are employees of Pfizer and hold stock and/or stock options. B Gundapaneni, an employee of inVentiv Health, was a paid contractor to Pfizer in association with providing statistical support for this analysis and contributing to manuscript development.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.